Scolmore International Limited is a privately held, limited company established in 1990, operating from its headquarters at Scolmore House Mariner, Tamworth, B79 7UL, UK. The company’s SIC codes are -46900, reflecting its classification as a non-specialised wholesale trade business. Scolmore Group, the parent entity, oversees the company’s strategic direction and growth. Scolmore has evolved significantly over three decades, initially focusing on the production of six core products – including the renowned ‘Scolmore’ wristwatches – and expanding into a diverse portfolio of over 9,000 offerings. This expansion reflects a sustained commitment to innovation and market adaptation. The company’s core business remains centered on the development and manufacture of specialized medical devices, primarily focused on the monitoring of blood pressure. Scolmore’s international presence is a key element of its strategy, with operations spanning across multiple continents. The company employs a skilled workforce, with a Worker (A rating) indicating a high level of expertise within the organization. Scolmore’s growth trajectory is driven by a focus on continuous improvement and strategic investment in research and development, ultimately aiming for sustained expansion and market leadership within its specialized medical device sector.

Scolmore International Limited is a privately held, limited company established in 1990, operating from its headquarters at Scolmore House Mariner, Tamworth, B79 7UL, UK. The company’s SIC codes are -46900, reflecting its classification as a non-specialised wholesale trade business. Scolmore Group, the parent entity, oversees the company’s strategic direction and growth. Scolmore has evolved significantly over three decades, initially focusing on the production of six core products – including the renowned ‘Scolmore’ wristwatches – and expanding into a diverse portfolio of over 9,000 offerings. This expansion reflects a sustained commitment to innovation and market adaptation. The company’s core business remains centered on the development and manufacture of specialized medical devices, primarily focused on the monitoring of blood pressure. Scolmore’s international presence is a key element of its strategy, with operations spanning across multiple continents. The company employs a skilled workforce, with a Worker (A rating) indicating a high level of expertise within the organization. Scolmore’s growth trajectory is driven by a focus on continuous improvement and strategic investment in research and development, ultimately aiming for sustained expansion and market leadership within its specialized medical device sector.